The findings of positron emission tomography (PET), performed very early during ABVD chemotherapy have been proven to be the most important prognostic information for predicting treatment outcome in patients with Hodgkin’s lymphoma treated with this chemotherapeutic regimen.[1][1],[2][2] However,
No takes yet. Share an insight, caveat, or question.
Andrea Gallamini (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: